LEP and breast cancer: As shown in Figure 4A, pretreatment with tamoxifen significantly alleviated leptin-induced increase in the populations of the cells in the S and G2-M phases in MCF-7 cells, whereas no significant change in each phase of the cell cycle was observed in MDA-MB-231 breast cancer cells (Figure 4B).